Safety and Reactogenicity of the ChAdOx1 (AZD1222) COVID-19 Vaccine in Saudi Arabia

INTRODUCTION: The Kingdom of Saudi Arabia was one of the first countries to implement a COVID-19 vaccination program. This study estimated the safety and reactogenicity of the ChAdOx1-S vaccine after the first dose administered to adults. METHODS: This cross-sectional study included 1592 randomly se...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Infect Dis
Main Authors: Al Bahrani, Salma, Albarrak, Ali, Alghamdi, Othman Ali, Alghamdi, Mesfer Abdullah, Hakami, Fatimah H., Al Abaadi, Asmaa K., Alkhrashi, Sausan A., Alghamdi, Mansour Y., Almershad, Meshael M., Alenazi, Mansour Moklif, El Gezery, Mohamed Hany, Jebakumar, Arulanantham Zechariah, Al-Tawfiq, Jaffar A.
Formato: Artigo
Idioma:Inglês
Publicado em: The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8310569/
https://ncbi.nlm.nih.gov/pubmed/34320413
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijid.2021.07.052
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados